Working… Menu
Trial record 1 of 1 for:    BNT162b2 pregnant
Previous Study | Return to List | Next Study

Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04754594
Recruitment Status : Recruiting
First Posted : February 15, 2021
Last Update Posted : August 17, 2021
Information provided by (Responsible Party):
BioNTech SE

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 15, 2022
Estimated Study Completion Date : October 15, 2022